Amedisys Inc ( (AMED) ) has released its Q3 earnings. Here is a breakdown of the information Amedisys Inc presented to its investors. Amedisys, ...

BATON ROUGE, La., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2024. Net service ...

The results fell short of Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $1.14 per share.

Leaders at UnitedHealth Group and Amedisys are set to meet with the Department of Justice (DOJ) this week in hopes of avoiding a potential attempt to block their $3.3 billion merger deal ...

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Amedisys (AMED).

UnitedHealth Group Inc. and Amedisys Inc. representatives are slated to meet with top Justice Department antitrust enforcers in a last-ditch effort to persuade the agency not to challenge their ...

Get prepared with the key expectations. Quest Diagnostics, Encompass Health, Amedisys and Addus HomeCare have been highlighted in this Industry Outlook article. Dependence on telehealth and AI ...

The company’s ROE of 17.8% compares favorably with the industry’s 8.2%. Amedisys: Amedisys, a well-known provider of home health, hospice and high-acuity care, reported its second-quarter 2024 ...

LinkedIn is not transparent about its use of the Insight Tag and the nature of the data it siphons. The plaintiffs attorneys cited LinkedIn's privacy policy, which states: "We will only collect ...

UnitedHealth Group (NYSE: UNH) and Amedisys (Nasdaq: AMED) leaders are reportedly expected to meet with officials from the Department of Justice over the next week to discuss their pending deal. The ...

Amedisys (Nasdaq: AMED) and UnitedHealth Group (NYSE: UNH) leaders were reportedly set to meet with officials from the U.S. Department of Justice (DOJ) this week over their pending deal. The DOJ’s ...

Copyright © 2024 MarketWatch, Inc. All rights reserved.